23 May 2013
Keywords: novartis, exelon, patch, launched, uk, swiss, drug
Article | 29 October 2007
Swiss drug major Novartis' Alzheimer's disease product Exelon (rivastigmine transdermal patch) is now available in the UK for the symptomatic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.